LoginJoin 2025 meeting Help pages

BOPSS TED Trials Webinar

7 pm Monday 12 June on Zoom

It has been a new dawn in bespoke medical therapies for thyroid eye disease since the FDA approval of Teprotumumab in the USA.

BOPSS have assembled a panel of TED Trial Investigators and other experts who can share their experiences and perspectives, to encourage wider UK participation and increase patient access to these exciting new therapies in the blossoming trial landscape.

More info here


This news post is in the following categories. Click the category button to view other pages in same category.

News